Ziegler Karin A, Engelhardt Stefan, Carnevale Daniela, McAlpine Cameron S, Guzik Tomasz J, Dimmeler Stefanie, Swirski Filip K
Institute of Pharmacology and Toxicology, School of Medicine and Health, Technical University of Munich, Germany (K.A.Z., S.E.).
German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany (K.A.Z., S.E.).
Circ Res. 2025 May 23;136(11):1233-1261. doi: 10.1161/CIRCRESAHA.125.325580. Epub 2025 May 22.
Although the neurocardiac axis is central to cardiovascular homeostasis, its dysregulation drives heart failure and cardiometabolic diseases. This review examines the bidirectional interplay between the autonomic nervous system and the heart, highlighting the role of this interplay in disease progression and its therapeutic potential. The autonomic nervous system modulates cardiac function and vascular tone through its sympathetic and parasympathetic branches. However, in heart failure, chronic sympathetic overdrive and parasympathetic withdrawal exacerbate myocardial remodeling and metabolic dysfunction, both of which are exacerbated by cardiometabolic conditions such as obesity and diabetes. These conditions are increasingly recognized to impair neurocardiac regulation, thereby promoting inflammation and adverse outcomes. An important emerging area concerns neuroimmune control, in which the brain orchestrates systemic inflammation through circuits involving the bone marrow, spleen, and other organs, thereby amplifying cardiovascular damage. This neuroimmune axis integrates peripheral signals to influence immune responses that contribute to disease progression. Lifestyle factors, such as stress, sleep, exercise, and diet, affect autonomic and immune balance and, thus, cardiovascular disease. Therapeutically, targeting neurocardiac and neuroimmune pathways pharmacologically or via neuromodulation (eg, vagal or splenic nerve stimulation) offers promise although the clinical translation of the latter remains challenging. In this review, we synthesize preclinical and clinical data to highlight the neurocardiac axis as a critical nexus in heart failure and cardiometabolic disease. Harnessing neuroimmune and neurocardiac interactions may inform precision approaches to reduce the burden of these conditions.
尽管神经心脏轴对于心血管稳态至关重要,但其失调会引发心力衰竭和心脏代谢疾病。本综述探讨了自主神经系统与心脏之间的双向相互作用,强调了这种相互作用在疾病进展中的作用及其治疗潜力。自主神经系统通过其交感神经和副交感神经分支调节心脏功能和血管张力。然而,在心力衰竭中,慢性交感神经过度兴奋和副交感神经退缩会加剧心肌重塑和代谢功能障碍,而肥胖和糖尿病等心脏代谢状况会使这两种情况进一步恶化。人们越来越认识到这些状况会损害神经心脏调节,从而促进炎症和不良后果。一个重要的新兴领域涉及神经免疫控制,即大脑通过涉及骨髓、脾脏和其他器官的回路协调全身炎症,从而加剧心血管损伤。这种神经免疫轴整合外周信号以影响有助于疾病进展的免疫反应。生活方式因素,如压力、睡眠、运动和饮食,会影响自主神经和免疫平衡,进而影响心血管疾病。在治疗方面,通过药物或神经调节(如迷走神经或脾神经刺激)靶向神经心脏和神经免疫途径具有前景,尽管后者的临床转化仍然具有挑战性。在本综述中,我们综合临床前和临床数据,以强调神经心脏轴是心力衰竭和心脏代谢疾病的关键联系。利用神经免疫和神经心脏相互作用可能为减轻这些疾病负担的精准方法提供依据。